Palo Alto Investors LP Kaleido Biosciences, Inc. Transaction History

Palo Alto Investors LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.05 - $1.7 $15,484 - $526,476	-309,692 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.3 - $2.7 $40,739 - $84,612	-31,338 Reduced 9.19%	309,692 $511,000
Q4 2021 Feb 14, 2022	SELL	$2.39 - $6.02 $1.06 Million - $2.68 Million	-445,370 Reduced 56.63%	341,030 $815,000
Q2 2020 Aug 14, 2020	SELL	$4.62 - $8.01 $7,387 - $12,807	-1,599 Reduced 0.2%	786,400 $5.84 Million
Q3 2019 Nov 14, 2019	SELL	$6.74 - $11.3 $530,215 - $888,937	-78,667 Reduced 9.08%	787,999 $5.93 Million
Q1 2019 May 15, 2019	BUY	$12.71 - $15.0 $11 Million - $13 Million	866,666 New	866,666 $12.6 Million

2.65K

Ticker KLDO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,622,600
Description
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...

Get notified when there are updates to the investment portfolio of Palo Alto Investors LP, based on Form 13F filings with the SEC.

Stay updated on Palo Alto Investors LP with notifications on news.